Skip to content

Goodwill at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$55.19B+18.7%
FactSet Research Systems logo
FactSet Research SystemsFDS
$1.29B+3.4%
Novanta logo
NovantaNOVT
$643.38M+9.2%
BWX Technologies logo
BWX TechnologiesBWXT
$496.26M+42.1%
Ralliant Corporation logo
Ralliant CorporationRAL
$1.62B
Charles River Laboratories logo
Charles River LaboratoriesCRL
$3.04B+5.8%

Segments

By segment

See full
Nuclear & Safety$1.23B+52.2%
Medical Segment$634M0.0%

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Mirion Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's goodwill?
Mirion Technologies (MIR) reported goodwill of $1.86B in Q1 2026.
How has Mirion Technologies's goodwill changed year-over-year?
Mirion Technologies's goodwill increased by 29.2% year-over-year, from $1.44B to $1.86B.
What is the long-term trend for Mirion Technologies's goodwill?
Over 4 years (2021 to 2025), Mirion Technologies's goodwill has grown at a 3.0% compound annual growth rate (CAGR), from $1.66B to $1.87B.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.